Skip to content

MAZE MAZE Interest Expense

Interest Expense at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.4M+17.6%
Zymeworks logo
ZymeworksZYME
$2.71M-20.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.71M-13.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.21M
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$5.12M-20.8%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's interest expense?
MAZE (MAZE) reported interest expense of $866K in Q1 2026.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.